$330.53
2.170.66%
At close: -
$330.01
-0.52-0.16%
After Hours: 8:22 AM EDT
Bio-Rad Laboratories reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bio-Rad Laboratories using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $2.01 | $1.16 | 73.3 % |
Jun 2024 | 2024-08-01 | $3.11 | $2.01 | 54.7 % |
Mar 2024 | 2024-05-07 | $2.29 | $2.15 | 6.51 % |
Dec 2023 | 2024-02-15 | $3.10 | $2.82 | 9.93 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $649.73M | $628.17M | 3.43 % |
Jun 2024 | 2024-08-01 | $638.48M | $645.79M | -1.13 % |
Mar 2024 | 2024-05-07 | $610.82M | $619.09M | -1.34 % |
Dec 2023 | 2024-02-15 | $681.18M | $685.09M | -0.57 % |
Bio-Rad Laboratories (BIO) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
The Actual EPS was $2.01, which beat the estimate of $1.16.
The Actual Revenue was $649.7M, which beat the estimate of $628.2M.
Browse earnings estimates, EPS, and revenue on all stocks.